Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Catalent Finishes First Batch of Flu Vax | Contract Pharma

What are you searching for?

Sign in
Breaking News

Catalent Finishes First Batch of Flu Vax

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Catalent Pharma Solutions, has completed the first influenza vaccine manufacturing campaign at its new prefilled syringe manufacturing facility in Neder-Over-Heembeek, Belgium.

The production campaign exceeded 21 million prefilled syringes for the 2007 campaign. The facility replaces existing operations in Brussels. Catalent received initial European regulatory approval for this facility in July 2006, and expects to have the first FDA product approved at the facility in 2008.

“We are pleased to be able to partner with our customers for products with such far-reaching public health benefit,” said Richard Yarwood, the Group President of Catalent’s Sterile Technologies segment. “Our new facility gives us substantial additional capacity to serve the high-demand prefilled syringe market globally.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters